City

Boston (1)

Chicago (1)

Jacksonville (1)

New York (1)

Portland (1)

Saint Louis (1)

Seattle (1)

Condition

Advanced Dedifferentiated Liposarcoma (2)

Locally Advanced Dedifferentiated Liposarcoma (1)

Metastatic Dedifferentiated Liposarcoma (1)

Stage III Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8 (1)

Stage IV Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8 (1)

Unresectable Dedifferentiated Liposarcoma (1)

Overall Status

Not yet recruiting (1)

Recruiting (1)

Phase

phase 2 (1)

phase 3 (1)

Sponsor

Alliance for Clinical Trials in Oncology (1)

Sarcoma Alliance for Research through Collaboration (1)

Collaborator

Eli Lilly and Company (1)

National Cancer Institute (NCI) (1)

Intervention

abemaciclib (1)

biospecimen collection (1)

cemiplimab (1)

computed tomography (1)

magnetic resonance imaging (1)

palbociclib (1)

placebo (1)

questionnaire administration (1)

Study Documents

Intervention Type

drug (2)

biological (1)

other (1)

procedure (1)

Funder Type

Other (2)

Study Type

Interventional (2)

advanced dedifferentiated liposarcoma

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Advanced Dedifferentiated Liposarcoma, Locally Advanced Dedifferentiated Liposarcoma, Metastatic Dedifferentiated Liposarcoma

Not yet recruiting

Advanced Dedifferentiated Liposarcoma
+5 more

Palbociclib
+5 more

(no location specified)

Jan 11, 2023

Advanced Dedifferentiated Liposarcoma Trial in United States (Abemaciclib, Placebo)

Recruiting

Advanced Dedifferentiated Liposarcoma

Abemaciclib
Placebo

Jacksonville, Florida
+6 more

Jul 27, 2022